Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

Clas-Goran af Bjorkesten, Urpo Nieminen, Ulla Turunen, Perttu Arkkila, Taina Sipponen, Martti Farkkila

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume47
Issue number5
Pages (from-to)528-537
Number of pages10
ISSN0036-5521
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • adalimumab
  • calprotectin
  • CDAI
  • combined activity index
  • Crohn's disease
  • Harvey-Bradshaw index
  • infliximab
  • SES-CD
  • INFLAMMATORY-BOWEL-DISEASE
  • FECAL CALPROTECTIN
  • PROSPECTIVE MULTICENTER
  • LACTOFERRIN
  • INFLIXIMAB
  • SEVERITY
  • SCORE
  • VALIDATION
  • STRATEGIES
  • 3121 Internal medicine

Cite this

@article{c8e1976577d8467c860b31a1713c27a8,
title = "Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease",
keywords = "adalimumab, calprotectin, CDAI, combined activity index, Crohn's disease, Harvey-Bradshaw index, infliximab, SES-CD, INFLAMMATORY-BOWEL-DISEASE, FECAL CALPROTECTIN, PROSPECTIVE MULTICENTER, LACTOFERRIN, INFLIXIMAB, SEVERITY, SCORE, VALIDATION, STRATEGIES, 3121 Internal medicine",
author = "{af Bjorkesten}, Clas-Goran and Urpo Nieminen and Ulla Turunen and Perttu Arkkila and Taina Sipponen and Martti Farkkila",
year = "2012",
doi = "10.3109/00365521.2012.660542",
language = "English",
volume = "47",
pages = "528--537",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "TAYLOR & FRANCIS LTD",
number = "5",

}

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. / af Bjorkesten, Clas-Goran; Nieminen, Urpo; Turunen, Ulla; Arkkila, Perttu; Sipponen, Taina; Farkkila, Martti.

In: Scandinavian Journal of Gastroenterology, Vol. 47, No. 5, 2012, p. 528-537.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

AU - af Bjorkesten, Clas-Goran

AU - Nieminen, Urpo

AU - Turunen, Ulla

AU - Arkkila, Perttu

AU - Sipponen, Taina

AU - Farkkila, Martti

PY - 2012

Y1 - 2012

KW - adalimumab

KW - calprotectin

KW - CDAI

KW - combined activity index

KW - Crohn's disease

KW - Harvey-Bradshaw index

KW - infliximab

KW - SES-CD

KW - INFLAMMATORY-BOWEL-DISEASE

KW - FECAL CALPROTECTIN

KW - PROSPECTIVE MULTICENTER

KW - LACTOFERRIN

KW - INFLIXIMAB

KW - SEVERITY

KW - SCORE

KW - VALIDATION

KW - STRATEGIES

KW - 3121 Internal medicine

U2 - 10.3109/00365521.2012.660542

DO - 10.3109/00365521.2012.660542

M3 - Article

VL - 47

SP - 528

EP - 537

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 5

ER -